|
US4920132A
(en)
*
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
|
US5324743A
(en)
*
|
1992-12-10 |
1994-06-28 |
Eli Lilly And Company |
Leukotriene B4 antagonists
|
|
GB2279659B
(en)
*
|
1993-07-05 |
1998-04-22 |
Merck Patent Gmbh |
Liquid crystalline material
|
|
WO1997026265A1
(en)
|
1996-01-17 |
1997-07-24 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
|
CA2244831A1
(en)
|
1996-02-02 |
1997-08-07 |
John T. Olson |
Method of treating diabetes and related disease states
|
|
WO1997028149A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
EP0904079B1
(en)
|
1996-02-02 |
2004-03-24 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
EP0882029B1
(en)
|
1996-02-02 |
2003-04-02 |
Merck & Co., Inc. |
Heterocyclic derivatives as antidiabetic and antiobesity agents
|
|
WO1997028115A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
JP3149958B2
(ja)
|
1996-08-30 |
2001-03-26 |
ノボ ノルディスク アクティーゼルスカブ |
Ｇｌｐ―１誘導体
|
|
AU719663B2
(en)
|
1996-12-23 |
2000-05-11 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
JP2003514508A
(ja)
|
1997-07-01 |
2003-04-15 |
ノボ ノルディスク アクティーゼルスカブ |
グルカゴン拮抗剤／逆作用剤
|
|
KR20010021936A
(ko)
|
1997-07-16 |
2001-03-15 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용
|
|
US6300364B1
(en)
|
1997-07-24 |
2001-10-09 |
Yamanouchi Pharmaceutical Co., Ltd. |
Medicinal compositions with cholesterol-lowering effect
|
|
EP1030665A4
(en)
|
1997-10-17 |
2002-11-27 |
Aventis Pharm Prod Inc |
THERAPEUTIC USE OF CHINOLINE DERIVATIVES
|
|
JP2003500432A
(ja)
*
|
1999-06-01 |
2003-01-07 |
ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター |
ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
|
|
GB9914977D0
(en)
|
1999-06-25 |
1999-08-25 |
Glaxo Group Ltd |
Chemical compounds
|
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
|
AU7995300A
(en)
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
EP1304121A4
(en)
|
1999-11-10 |
2004-06-23 |
Takeda Chemical Industries Ltd |
INHIBITORS OF BODY WEIGHT GAIN
|
|
AU778829B2
(en)
|
1999-11-11 |
2004-12-23 |
Eli Lilly And Company |
Oncolytic combinations for the treatment of cancer
|
|
CA2400021A1
(en)
|
2000-02-18 |
2001-08-23 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
IL151517A0
(en)
|
2000-03-09 |
2003-04-10 |
Aventis Pharma Gmbh |
Therapeutic uses of ppar mediators
|
|
US6448293B1
(en)
*
|
2000-03-31 |
2002-09-10 |
Pfizer Inc. |
Diphenyl ether compounds useful in therapy
|
|
JP2001354671A
(ja)
|
2000-04-14 |
2001-12-25 |
Nippon Chemiphar Co Ltd |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
FR2812876B1
(fr)
*
|
2000-08-08 |
2002-09-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
ATE542805T1
(de)
|
2000-08-11 |
2012-02-15 |
Nippon Chemiphar Co |
Ppar-delta aktivatoren
|
|
US6630504B2
(en)
*
|
2000-08-31 |
2003-10-07 |
Pfizer Inc. |
Phenoxyphenylheterocyclyl derivatives as SSRIs
|
|
GB0024361D0
(en)
|
2000-10-05 |
2000-11-22 |
Glaxo Group Ltd |
Medicaments
|
|
JPWO2002046154A1
(ja)
|
2000-12-05 |
2004-04-08 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
GB0031103D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0031109D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0031107D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
CA2433573A1
(en)
|
2000-12-28 |
2002-07-11 |
Takeda Chemical Industries, Ltd. |
Alkanoic acid derivatives, process for their production and use thereof
|
|
WO2002070011A2
(en)
|
2001-02-02 |
2002-09-12 |
Smithkline Beecham Corporation |
Treatment of ppar mediated diseases
|
|
US7078422B2
(en)
|
2001-03-23 |
2006-07-18 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-activated receptor
|
|
JP4256166B2
(ja)
|
2001-03-28 |
2009-04-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
カルボン酸化合物
|
|
WO2002080899A1
(fr)
|
2001-03-30 |
2002-10-17 |
Eisai Co., Ltd. |
Agent de traitement de maladie digestive
|
|
TWI311133B
(en)
|
2001-04-20 |
2009-06-21 |
Eisai R&D Man Co Ltd |
Carboxylic acid derivativeand the salt thereof
|
|
JPWO2002098840A1
(ja)
|
2001-06-04 |
2004-09-16 |
エーザイ株式会社 |
カルボン酸誘導体及びその塩もしくはそのエステルからなる医薬
|
|
FR2826574B1
(fr)
|
2001-06-29 |
2005-08-26 |
Oreal |
Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles
|
|
RU2004105956A
(ru)
*
|
2001-07-30 |
2005-03-27 |
Ново Нордиск А/С (DK) |
Новые производные винилкарбоновых кислот и их применение в качестве антидиабетических средств и т.п.
|
|
BRPI0211844B8
(pt)
|
2001-08-10 |
2021-05-25 |
Nippon Chemiphar Co |
composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
|
|
JPWO2003016265A1
(ja)
|
2001-08-17 |
2004-12-02 |
エーザイ株式会社 |
環状化合物およびｐｐａｒアゴニスト
|
|
BR0212512A
(pt)
|
2001-09-14 |
2004-10-26 |
Tularik Inc |
Composto, composição farmacêutica e métodos para tratar um distúrbio, condição ou doença, elevar os nìveis do colesterol hdl, reduzir os nìveis de triglicerìdeo, tratar diabete, diminuir a resistência à insulina ou diminuir a pressão arterial e modular a ppardelta
|
|
ES2326411T3
(es)
|
2001-10-12 |
2009-10-09 |
Nippon Chemiphar Co., Ltd. |
Activador del receptor delta activado por proliferadores de peroxisomas.
|
|
JP2005505616A
(ja)
|
2001-10-17 |
2005-02-24 |
ノボ ノルディスク アクティーゼルスカブ |
ジカルボン酸誘導体、それらの調製、並びに治療上の用途
|
|
DE10151390A1
(de)
|
2001-10-18 |
2003-05-08 |
Bayer Ag |
Essigsäurederivate
|
|
JP2003171275A
(ja)
|
2001-12-11 |
2003-06-17 |
Sumitomo Pharmaceut Co Ltd |
ＰＰＡＲδアゴニスト
|
|
US6648293B1
(en)
*
|
2001-12-20 |
2003-11-18 |
Braeside Plastics Corporation |
Foldable display container and method for assembling the same
|
|
JP2005529077A
(ja)
|
2002-02-25 |
2005-09-29 |
イーライ・リリー・アンド・カンパニー |
ペルオキシソーム増殖因子活性化受容体調節物質
|
|
EP1480957A1
(en)
|
2002-03-01 |
2004-12-01 |
Smithkline Beecham Corporation |
Hppars activators
|
|
US20030207924A1
(en)
|
2002-03-07 |
2003-11-06 |
Xue-Min Cheng |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6833380B2
(en)
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6867224B2
(en)
|
2002-03-07 |
2005-03-15 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6875780B2
(en)
*
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
|
DE10222034A1
(de)
|
2002-05-17 |
2003-11-27 |
Bayer Ag |
Tetrahydroisochinolin-Derivate
|
|
GB0214149D0
(en)
|
2002-06-19 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
WO2004007439A1
(ja)
*
|
2002-07-10 |
2004-01-22 |
Sumitomo Pharmaceuticals Co., Ltd. |
ビアリール誘導体
|
|
WO2004056740A1
(en)
|
2002-12-20 |
2004-07-08 |
Novo Nordisk A/S |
Dicarboxylic acid derivatives as ppar-agonists
|
|
US7816385B2
(en)
*
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
|
AU2003296401A1
(en)
|
2003-01-06 |
2004-08-10 |
Eli Lilly And Company |
A pyrazole derivative as ppar modulator
|
|
DE10300099A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Indol-Phenylsulfonamid-Derivate
|
|
EP1594847A2
(en)
*
|
2003-02-12 |
2005-11-16 |
Transtech Pharma, Inc. |
Substituted azole derivatives as therapeutic agents
|
|
BRPI0407180A
(pt)
|
2003-02-14 |
2006-02-07 |
Lilly Co Eli |
Composto, composição farmacêutica, métodos para modular um receptor ativado pelo proliferador de peroxissoma, para tratar ou prevenir uma doença ou condição, para diminuir a glicose no sangue em um mamìfero, para tratar ou prevenir diabetes mellitus, doença cardiovascular e sìndrome x em um mamìfero, e, uso de um composto
|
|
JPWO2004080943A1
(ja)
|
2003-03-11 |
2006-06-08 |
小野薬品工業株式会社 |
シンナミルアルコール誘導体化合物およびその化合物を有効成分として含有する薬剤
|
|
JPWO2004080947A1
(ja)
|
2003-03-13 |
2006-06-08 |
小野薬品工業株式会社 |
イミノエーテル誘導体化合物およびその化合物を有効成分として含有する薬剤
|
|
WO2004092117A1
(en)
|
2003-04-07 |
2004-10-28 |
Kalypsys, Inc. |
Para-sulfonyl substituted phenyl compounds as modulators of ppars
|
|
US20050070532A1
(en)
|
2003-04-17 |
2005-03-31 |
Liu Kevin |
Aryl compounds as modulators of PPARS and methods of treating metabolic disorders
|
|
US7244763B2
(en)
|
2003-04-17 |
2007-07-17 |
Warner Lambert Company Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
EA200501713A1
(ru)
|
2003-04-30 |
2006-06-30 |
ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи |
Фенилзамещённые карбоновые кислоты
|
|
WO2005054176A1
(en)
*
|
2003-11-25 |
2005-06-16 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
BRPI0509540A
(pt)
|
2004-04-01 |
2007-09-18 |
Aventis Pharma Inc |
uso de agonistas do receptor delta ativado pelo proliferador de peroxissoma para o tratamento de ms e outras doenças desmielinizantes
|
|
RU2375358C2
(ru)
|
2004-04-01 |
2009-12-10 |
Авентис Фармасьютикалз, Инк. |
1,3,4-оксадиазол-2-оны в качестве модуляторов ppar-дельта и их применение
|
|
AU2005230838A1
(en)
|
2004-04-01 |
2005-10-20 |
Aventis Pharmaceuticals Inc. |
1,3,4-oxadiazol-2-ones as PPAR delta
|
|
WO2005105726A1
(en)
|
2004-05-05 |
2005-11-10 |
Novo Nordisk A/S |
Novel compounds, their preparation and use
|
|
EP1756062A4
(en)
|
2004-05-14 |
2008-01-02 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
|
|
CA2645719A1
(en)
*
|
2006-03-09 |
2007-09-13 |
High Point Pharmaceuticals, Llc |
Compounds that modulate ppar activity, their preparation and use
|